The role of direct antiviral agents for the treatment of chronic hepatitis C in special populations

  • Mã bài báo : EN0803
  • Ngày xuất bản : 29/04/2021
  • Số trang : 34-48
  • Tác giả : Do Van Thanh
  • Lượt xem : ( 343 )

Danh sách tác giả (*)

  • Do Van Thanh 1 - Center for Tropical Diseases, Bach Mai Hospital

 https://doi.org/10.52322/jocmbmh.08.en.03

ABSTRACT

Hepatitis C virus (HCV) infection is a serious public health problem globally. With the advent of direct-acting antivirals (DAA), HCV therapy has shifted dramatically. In the great majority of instances, DAA treatment is substantially more effective than prior IFN-based regimens. The high prevalence of HCV infection was recognized in HIV patients (with history of injecting drugs), patients undergone dialysis or cirrhosis patients. Meanwhile, DAA treatment in these groups has several differences compared to the general population. This paper aims to review the current DAAs therapy for HCV treatment and its management in special populations.

Keywords: Direct antiviral agents, DAAs, chronic HCV, hepatitis C.

  • Chủ đề : Infectious Diseses
  • Loại bài báo : Review Articles
  • Chuyên nghành : Clinical Medicine

File toàn văn

Chưa có mã code, vui lòng liên hệ để nhận mã theo số điện thoại : 0947040855 - Email : jocm@bachmai.edu.vn

  • Thông tin liên hệ : Do Van Thanh
  • Email :
  • Địa chỉ : Center for Tropical Diseases, Bach Mai Hospital

Bài báo liên quan

Nhà tài trợ và đối tác